Metavia Stock Today
| MTVA Stock | 1.54 0.10 6.10% |
PerformanceWeakest
| Odds Of DistressSmall
|
MetaVia is trading at 1.54 as of the 18th of February 2026, a 6.1% down since the beginning of the trading day. The stock's open price was 1.64. MetaVia has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of November 2025 and ending today, the 18th of February 2026. Click here to learn more.
Moving against MetaVia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MetaVia Stock Highlights
| President CEO | HyungHeon Kim |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
MetaVia (MTVA) is traded on NASDAQ Exchange in USA and employs 9 people. MetaVia is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.44 M. MetaVia conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.32 M outstanding shares of which 62.41 K shares are now shorted by private and institutional investors with about 0.24 trading days to cover.
MetaVia generates negative cash flow from operations
Check MetaVia Probability Of Bankruptcy
Ownership AllocationMetaVia holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check MetaVia Ownership Details
MetaVia Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. MetaVia market risk premium is the additional return an investor will receive from holding MetaVia long position in a well-diversified portfolio.
| Mean Deviation | 6.97 | |||
| Standard Deviation | 11.01 | |||
| Variance | 121.15 | |||
| Risk Adjusted Performance | (0.13) |
MetaVia Stock Against Markets
MetaVia Corporate Management
| Michael Pine | Senior Advisor | Profile | |
| Marshall Woodworth | Chief Officer | Profile | |
| Christopher MD | Consulting Advisor | Profile | |
| Robert Homolka | Senior Operations | Profile | |
| MiKyung Kim | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetaVia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetaVia. Expected growth trajectory for MetaVia significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MetaVia assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding MetaVia requires distinguishing between market price and book value, where the latter reflects MetaVia's accounting equity. The concept of intrinsic value - what MetaVia's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MetaVia's price substantially above or below its fundamental value.
Understanding that MetaVia's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MetaVia represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MetaVia's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.